ASCT-83
/ Alcamena Stem Cell Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 17, 2026
Safety, Tolerability, and Pharmacokinetics of ASCT-83 in Healthy Adults
(clinicaltrials.gov)
- P1 | N=72 | Recruiting | Sponsor: Alcamena Stem Cell Therapeutics | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Neuralgia • Pain
1 to 1
Of
1
Go to page
1